<?xml version="1.0" encoding="UTF-8"?>
<p>Maggot debridement therapy was developed in 1930s to treat chronic ulcers and infections of patients with diabetes and heart diseases (
 <xref rid="B12" ref-type="bibr">Malekian et al., 2019</xref>). Larvae of the green bottle fly 
 <italic>Lucilia sericata</italic> was used for this therapy and the mechanism involved secretion of large amount different AMPs including proline rich peptides (PRPs) into the wound that promote wound healing (
 <xref rid="B18" ref-type="bibr">van der Plas et al., 2007</xref>). To elucidate the mechanism of PRPs, 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00532" xmlns:xlink="http://www.w3.org/1999/xlink">Cytrynska et al.</ext-link> investigated effect of two PRPs (Lser-PRP2 and Lser-PRP3) in 
 <italic>E. coli</italic>. It was found that neither of AMPs interfered with protein synthesis rather bind the bacterial chaperone DnaK that inhibit protein folding. This study indicated that insect AMPs another promising source of antibacterial agents for targeted antimicrobial therapy.
</p>
